https://adisinsight.springer.com/drugsafety/803928593?error=cookies_not_supported&code=56613a2b-f79e-47b7-8021-cfde8d763b64
Elexacaftor/ivacaftor/tezacaftor - AdisInsight
Eleven patients [age and sex not stated] with cystic fibrosis in France were treated with elexacaftor-tezacaftor-ivacaftor and were reported as requiring lung
adisinsight
https://adisinsight.springer.com/drugsafety/803859699?error=cookies_not_supported&code=20e202b2-6c7c-43c6-8c20-55df31e4e9a6
Elexacaftor/Ivacaftor/tezacaftor - AdisInsight
In a study of 447 children conducted between 2022 and 2023, a child [sex and exact age not stated] was described, who developed liver parameter elevation during
adisinsight
https://pubmed.ncbi.nlm.nih.gov/30334692/
VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
The use of VX-445-tezacaftor-ivacaftor to target Phe508del CFTR protein resulted in increased CFTR function in vitro and translated to improvements in patients...
https://adisinsight.springer.com/drugsafety/803926771?error=cookies_not_supported&code=31abb67b-e853-4412-8870-db2299e17227
Elexacaftor/ivacaftor/tezacaftor - AdisInsight
Seventeen patients with cystic fibrosis who had undergone lung transplantation received elexacaftor/tezacaftor/ivacaftor and experienced adverse drug reactions
adisinsight
https://pubmed.ncbi.nlm.nih.gov/38950554/
Behavioural and sleep issues after initiation of elexacaftor-tezacaftor-ivacaftor in preschool-age...
Behavioural and sleep issues after initiation of elexacaftor-tezacaftor-ivacaftor in preschool-age children with cystic fibrosis
https://pubmed.ncbi.nlm.nih.gov/38226069/
Cystic fibrosis airway inflammation enables elexacaftor/tezacaftor/ivacaftor-mediated rescue of...
cystic fibrosisairwayinflammation
https://profiles.wustl.edu/en/publications/the-impact-of-elexacaftortezacaftorivacaftor-on-body-composition-/
The impact of elexacaftor/tezacaftor/ivacaftor on body composition in a small cohort of youth with...
https://pmc.ncbi.nlm.nih.gov/articles/PMC12418867/
Elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis harbouring two CFTR Class I...
The European Medicines Agency has recently expanded the label of elexacaftor-tezacaftor-ivacaftor (ETI) to all people with cystic fibrosis (pwCF) aged 2 years...
https://medlineplus.gov/druginfo/meds/a619061.html
Elexacaftor, Tezacaftor, and Ivacaftor: MedlinePlus Drug Information
Elexacaftor, Tezacaftor, and Ivacaftor: learn about side effects, dosage, special precautions, and more on MedlinePlus
medlineplusdruginformation
https://pubchem.ncbi.nlm.nih.gov/compound/Elexacaftor_-ivacaftor_-tezacaftor_-ivacaftor
Elexacaftor, ivacaftor, tezacaftor; ivacaftor - PubChem
Elexacaftor, ivacaftor, tezacaftor; ivacaftor chemical information summary.
pubchem
https://adisinsight.springer.com/drugsafety/803923782?error=cookies_not_supported&code=d7fdc2e6-2985-4c7e-a148-0f0950c383fb
Elexacaftor/Ivacaftor/Tezacaftor - AdisInsight
Two children with cystic fibrosis developed hyperbilirubinaemia during treatment with elexacaftor, tezacaftor and ivacaftor. Both children, who had a history of
adisinsight